Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glemanserin (MDL11939) is a specific 5-HT2A antagonist with Ki values of 0.54 nM, 2.5 nM and 2.89 nM for rabbit, human and rat 5-HT2A.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 287.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 672.00 | |
500 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 81.00 |
Description | Glemanserin (MDL11939) is a specific 5-HT2A antagonist with Ki values of 0.54 nM, 2.5 nM and 2.89 nM for rabbit, human and rat 5-HT2A. |
In vivo | Intracortical administration of Glemanserin attenuates dopamine release induced by systemic administration of the 5-HT2 agonist DOI. Glemanserin suppresses Morphine-induced increase in withdrawal symptoms, locomotor activity, and behavioral sensitization in mice[1]. |
Synonyms | MDL11939 |
Molecular Weight | 295.42 |
Formula | C20H25NO |
CAS No. | 107703-78-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.2 mg/mL (24.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glemanserin 107703-78-6 GPCR/G Protein Neuroscience 5-HT Receptor MDL 11939 MDL11939 MDL-11939 inhibitor inhibit